Medscape Pharmacotherapy HeadlinesLatest medical news and information from Medscape.comDMARDs May Protect Against Cardiovascular Disease in Rheumatoid Arthritis Patients- June 11, 2004 Using U.S. health insurance claims, the investigators show a cardiac benefit for DMARDs and confirm potential harm from COX-2 inhibitors. Medscape Medical NewsPaula Moyerhttp://www.medscape.com/viewarticle/480716?rss Tiagabine May Be Useful Insomnia Treatment for Adults- June 11, 2004 In a preliminary study, moderate doses of this anticonvulsant drug reduced waking after sleep onset and enhanced deep sleep stages in adults with primary insomnia.Medscape Medical Newshttp://www.medscape.com/viewarticle/480748?rss An Update on the Management of Voiding Disorders- June 11, 2004 Read clinically focused news coverage of key developments from the meeting.Medscape Medical Newshttp://www.medscape.com/viewarticle/480672?rss Relapsed Ovarian Cancer Responds to Pegylated Liposomal Doxorubicin-Carboplatin- June 10, 2004 The treatment reduces alopecia and neurotoxicity.Medscape Medical NewsPeggy Peckhttp://www.medscape.com/viewarticle/480628?rss Oral Agents as Good as Bolus 5-FU-Leucovorin Regimens for Adjuvant Treatment of Colon Cancer- June 10, 2004 The capecitabine results show a trend toward superior results.Medscape Medical NewsPeggy Peckhttp://www.medscape.com/viewarticle/480627?rss Gemcitabine Plus Paclitaxel Increases Survival in Metastatic Breast Cancer- June 10, 2004 Time to progression is also significantly better than with paclitaxel alone, and the combination does not increase toxicity.Medscape Medical Newshttp://www.medscape.com/viewarticle/480637?rss Pharmacists, May 2004- June 10, 2004 Effect of prophylactic magnesium on the occurrence of torsades de pointes associated with ibutilide; factors that influence prescribing and use of medications; ACE inhibitors in managed care settingsMedscape Pharmacistshttp://www.medscape.com/viewarticle/479794?rss Letrozole Increases Survival Rate in Node-Positive Breast Cancer- June 10, 2004 Updated findings from the MA-17 trial indicate a 39% survival benefit with letrozole, which also reduced the risk of local recurrence and distant metastases.Medscape Medical Newshttp://www.medscape.com/viewarticle/480638?rss FDA Drug and Device Approvals: June 10, 2004- June 10, 2004 The FDA has approved a new test for anthrax, a lower dose of an estradiol transdermal system, a new formulation of timolol maleate ophthalmic solution 0.5%, insulin lispro injection for use in external insulin pumps, and low-dose injectable epinephrine for low-weight patients.Medscape Medical Newshttp://www.medscape.com/viewarticle/480642?rss Rosuvastatin Label Change in EU Indicates Risk of Myopathy- June 10, 2004 The European Union labeling changes reflect risk of muscle toxicity associated with increased drug levels.MedscapeYael Wakninehttp://www.medscape.com/viewarticle/480577?rss |